Zhouxian Bai1, Boryana Stamova, Huichun Xu, Bradley P Ander, Jiajia Wang, Glen C Jickling, Xinhua Zhan, DaZhi Liu, Guangchun Han, Lee-Way Jin, Charles DeCarli, Hongxing Lei, Frank R Sharp. 1. *CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences †CAS Key Laboratory of Genome Sciences and Information, University of Chinese Academy of Sciences, Beijing, China ‡Department of Neurology and MIND Institute, School of Medicine ∥Alzheimer's Disease Center, School of Medicine, University of California at Davis, Sacramento, CA §Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Defining the RNA transcriptome in Alzheimer Disease (AD) will help understand the disease mechanisms and provide biomarkers. Though the AD blood transcriptome has been studied, effects of white matter hyperintensities (WMH) were not considered. This study investigated the AD blood transcriptome and accounted for WMH. METHODS: RNA from whole blood was processed on whole-genome microarrays. RESULTS: A total of 293 probe sets were differentially expressed in AD versus controls, 5 of which were significant for WMH status. The 288 AD-specific probe sets classified subjects with 87.5% sensitivity and 90.5% specificity. They represented 188 genes of which 29 have been reported in prior AD blood and 89 in AD brain studies. Regulated blood genes included MMP9, MME (Neprilysin), TGFβ1, CA4, OCLN, ATM, TGM3, IGFR2, NOV, RNF213, BMX, LRRN1, CAMK2G, INSR, CTSD, SORCS1, SORL1, and TANC2. CONCLUSIONS: RNA expression is altered in AD blood irrespective of WMH status. Some genes are shared with AD brain.
BACKGROUND: Defining the RNA transcriptome in Alzheimer Disease (AD) will help understand the disease mechanisms and provide biomarkers. Though the AD blood transcriptome has been studied, effects of white matter hyperintensities (WMH) were not considered. This study investigated the AD blood transcriptome and accounted for WMH. METHODS: RNA from whole blood was processed on whole-genome microarrays. RESULTS: A total of 293 probe sets were differentially expressed in AD versus controls, 5 of which were significant for WMH status. The 288 AD-specific probe sets classified subjects with 87.5% sensitivity and 90.5% specificity. They represented 188 genes of which 29 have been reported in prior AD blood and 89 in AD brain studies. Regulated blood genes included MMP9, MME (Neprilysin), TGFβ1, CA4, OCLN, ATM, TGM3, IGFR2, NOV, RNF213, BMX, LRRN1, CAMK2G, INSR, CTSD, SORCS1, SORL1, and TANC2. CONCLUSIONS: RNA expression is altered in AD blood irrespective of WMH status. Some genes are shared with AD brain.
Authors: Micha M M Wilhelmus; Sentini C S Grunberg; John G J M Bol; Anne-Marie van Dam; Jeroen J M Hoozemans; Annemieke J M Rozemuller; Benjamin Drukarch Journal: Brain Pathol Date: 2008-07-31 Impact factor: 6.508
Authors: Huichun Xu; Boryana Stamova; Glen Jickling; Yingfang Tian; Xinhua Zhan; Bradley P Ander; Dazhi Liu; Renée Turner; Jonathan Rosand; Larry B Goldstein; Karen L Furie; Piero Verro; S Claiborne Johnston; Frank R Sharp; Charles S Decarli Journal: Stroke Date: 2010-10-21 Impact factor: 7.914
Authors: Brian Spencer; Robert A Marr; Ryan Gindi; Rewati Potkar; Sarah Michael; Anthony Adame; Edward Rockenstein; Inder M Verma; Eliezer Masliah Journal: PLoS One Date: 2011-01-31 Impact factor: 3.240
Authors: Young Ho Park; Angela Hodges; Shannon L Risacher; Kuang Lin; Jae-Won Jang; Soyeon Ahn; SangYun Kim; Simon Lovestone; Andrew Simmons; Michael W Weiner; Andrew J Saykin; Kwangsik Nho Journal: Neurobiol Aging Date: 2019-12-10 Impact factor: 4.673
Authors: Md Sahab Uddin; Anna Stachowiak; Abdullah Al Mamun; Nikolay T Tzvetkov; Shinya Takeda; Atanas G Atanasov; Leandro B Bergantin; Mohamed M Abdel-Daim; Adrian M Stankiewicz Journal: Front Aging Neurosci Date: 2018-01-30 Impact factor: 5.750
Authors: Cristina M Pedrero-Prieto; Alicia Flores-Cuadrado; Daniel Saiz-Sánchez; Isabel Úbeda-Bañón; Javier Frontiñán-Rubio; Francisco J Alcaín; Lourdes Mateos-Hernández; José de la Fuente; Mario Durán-Prado; Margarita Villar; Alino Martínez-Marcos; Juan R Peinado Journal: Alzheimers Res Ther Date: 2019-06-29 Impact factor: 6.982
Authors: Elizabeth E Blue; Timothy A Thornton; Charles Kooperberg; Simin Liu; Jean Wactawski-Wende; JoAnn Manson; Lew Kuller; Kathleen Hayden; Alexander P Reiner Journal: Alzheimers Dement Date: 2020-09-23 Impact factor: 21.566